Overview and Scope
Immunoglobins refer to glycoproteins, often known as antibodies, that are created by plasma cells (white blood cells). They play a crucial role in the immune response by selectively identifying and attaching to specific antigens, such as viruses or bacteria, and assisting in their eradication.
Sizing and Forecast
The immunoglobulins market size has grown strongly in recent years. It will grow from $17.49 billion in 2023 to $19.07 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases.
The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $28.3 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness.. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
Segmentation & Regional Insights
The immunoglobulins market covered in this report is segmented –
1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode of Delivery, Subcutaneous Mode of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications
North America was the largest region in the immunoglobulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp
Major Driver Impacting Market Growth
The increasing geriatric population drives the growth of the immunoglobulins market. The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body’s ability to produce antibodies that protect it from bacteria, viruses, and allergies. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period.
Key Industry Players
Major companies operating in the immunoglobulins market report are Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Blood Diagnostic Pharma Inc., Bio Products Laboratory Ltd., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Catalyst Biosciences Inc., Cytiva Corporation, Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited
The immunoglobulins market report table of contents includes:
1. Executive Summary
2. Immunoglobulins Market Characteristics
3. Immunoglobulins Market Trends And Strategies
4. Immunoglobulins Market – Macro Economic Scenario
5. Global Immunoglobulins Market Size and Growth
.
.
.
31. Global Immunoglobulins Market Competitive Benchmarking
32. Global Immunoglobulins Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Immunoglobulins Market
34. Immunoglobulins Market Future Outlook and Potential Analysis
35. Appendix
Top Major Players:
Baxter International Inc
CSL Behring LLC
Grifols S. A
Octapharma AG
China Biologic Products Holdings Inc
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
